You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serotonin Uptake Inhibitors

Showing 26 - 50 of 7,752
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in San Francisco (Standard Clinical Care with an SRRI)

Recruiting
  • Major Depressive Disorder
  • Standard Clinical Care with an SRRI
  • San Francisco, California
    University of California San Francisco
Mar 2, 2022

MDD Trial in Shanghai (SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors),

Not yet recruiting
  • Major Depressive Disorder
  • SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
  • +2 more
  • Shanghai, Shanghai, China
  • +3 more
Aug 24, 2020

Depression Trial in Winston-Salem (Fluoxetine 20 MG, Duloxetine 30 MG, Observation)

Not yet recruiting
  • Depression
  • Fluoxetine 20 MG
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 28, 2023

Suicidal Ideation, Depression Trial in Xi'an (Robot-assisted rTMS combined with serotonin-norepinephrine reuptake

Recruiting
  • Suicidal Ideation
  • Depression
  • Robot-assisted rTMS combined with serotonin-norepinephrine reuptake inhibitors(SNRIs)
  • +2 more
  • Xi'an, Shaanxi, China
    XijingH
Jan 8, 2021

Depression Trial in Atlanta (drug, behavioral, other)

Completed
Has Results
  • Depression
  • Selective serotonin re-uptake inhibitor
  • +2 more
  • Atlanta, Georgia
    12 Executive Park Drive, 3rd floor
Oct 13, 2020

Nocturnal Enuresis Trial in Mansoura (Fluoxetine, Placebo)

Unknown status
  • Nocturnal Enuresis
  • Mansoura, Dakahlia, Egypt
    Mansoura urology and nephrology center
Dec 15, 2020

Geriatric Depression, Cognitive Impairment Trial in Beijing (Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine,

Recruiting
  • Geriatric Depression
  • Cognitive Impairment
  • Selective Serotonin Reuptake Inhibitor（SSRIs，Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram）
  • Beijing, China
    Beijing Anding Hospital Affiliated to Capital Medical University
Oct 18, 2022

Epilepsy Trial in Shanghai (psychology therapy)

Active, not recruiting
  • Epilepsy
  • psychology therapy
  • Shanghai, Shanghai, China
    Department of Neurology, Zhongshan Hospital, Fudan University, S
Dec 19, 2021

Depressive Disorder Trial in Japan (323U66 (Bupropion Hydrochloride Sustained Release), Placebo)

Completed
Has Results
  • Depressive Disorder
  • 323U66 (Bupropion Hydrochloride Sustained Release)
  • Placebo
  • Aichi, Japan
  • +61 more
Nov 19, 2019

Major Depression Trial in Tartu (escitalopram, bupropion)

Completed
Has Results
  • Major Depression
  • Tartu, Estonia
    Department of Psychiatry, University of Tartu
Apr 24, 2019

MDD Trial in Dhaka (SSRI with Zinc Sulfate)

Completed
  • MDD
  • SSRI with Zinc Sulfate
  • Dhaka, Bangladesh
    BSMMU
Jan 26, 2021

Healthy Trial (Fluoxetine, Bupropion)

Completed
Has Results
  • Healthy
  • (no location specified)
Nov 16, 2020

OCD Trial in Hamilton (SSRIs)

Completed
  • Obsessive-Compulsive Disorder
  • Hamilton, Ontario, Canada
    MacAnxiety Research Centre
Aug 31, 2020

PTSD Trial in United States (Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written

Recruiting
  • PTSD
  • Selective serotonin reuptake inhibitor
  • +2 more
  • North Little Rock, Arkansas
  • +15 more
Aug 2, 2022

DaTSCAN Brain Scintigraphy and Psychotropic Treatments:

Not yet recruiting
  • Parkinson Disease
  • scintigraphy DaTSCAN
  • Vandœuvre-lès-Nancy, France
    CHRU Nancy
Jan 5, 2023

Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

Recruiting
  • Non Small Cell Lung Cancer
  • FAPI PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Oct 24, 2023

Depression Trial in Karachi (chamomile tea n saffron)

Active, not recruiting
  • Depression
  • chamomile tea n saffron
  • Karachi, PK, Pakistan
    Aga Khan University
Nov 16, 2022

Pharmacogenetics of Antidepressant-Induced Disinhibition

Recruiting
  • Obsessive-Compulsive Disorder
  • +3 more
    • Calgary, Alberta, Canada
      Child and Adolescent Addiction, Mental Health & Psychiatry
    Nov 4, 2022

    Parkinson Disease Trial in Toulouse (Clinical assessment, Pain characteristics assessment, MRI)

    Not yet recruiting
    • Parkinson Disease
    • Clinical assessment
    • +5 more
    • Toulouse, Haute-Garonne, France
      Centre Hospitalier Universitaire de Toulouse
    Aug 22, 2023

    Taste Supra-thresholds AmongSample of Depressed Egyptian Adult

    Completed
    • Taste Disorders
      • Cairo, Egypt
        Faculty of Dentistry, Cairo University
      Feb 2, 2022

      Type2 Diabetes, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Empagliflozin 25 MG, Placebo)

      Recruiting
      • Type2 Diabetes
      • Heart Failure With Preserved Ejection Fraction
      • Empagliflozin 25 MG
      • Placebo
      • San Antonio, Texas
      • +1 more
      Jan 21, 2023

      Investigating Serotonin Signalling in IBD Patients

      Recruiting
      • Inflammatory Bowel Disease
        • Hamilton, Ontario, Canada
          McMaster University Medical Center
        Sep 9, 2021

        Depression, HIV Trial in Kampala (Group Pyschotherapy, Depression Standard of Care, HIV Standard of Care)

        Recruiting
        • Depression
        • HIV
        • Group Pyschotherapy
        • +2 more
        • Kampala, Uganda
          Infectious Diseases Institute
        Oct 29, 2022

        Depression, Opioid Use Disorder Trial in Ukraine (Project ECHO, Payment for Performance)

        Active, not recruiting
        • Depression
        • Opioid Use Disorder
        • Project ECHO
        • Payment for Performance
        • Ivano-Frankivs'k, Ukraine
        • +8 more
        Dec 1, 2022

        Opioid Induced Respiratory Depression, Depressive Disorder, Anxiety Disorders Trial (Oxycodone Hydrochloride, Placebo)

        Not yet recruiting
        • Opioid Induced Respiratory Depression
        • +2 more
        • Oxycodone Hydrochloride
        • Placebo
        • (no location specified)
        Feb 14, 2023